At Pharmacy Benefit Management Institute (PBMI) annual conference, Prime received two awards: one for cost savings, another for leadership.

Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

Prime Therapeutics is committed to simplifying the patient journey for those with complex conditions through its industry-leading HighTouchRx product

Tap into solutions that deliver real value The best Medicare and Managed Medicaid programs are ones that are customized to your needs and member population. Let us put our 40+ years of experience...

California Privacy Notice and Policy Prime Therapeutics LLC and all its divisions and subsidiaries (collectively, (“Company”, “Prime”, “we” or “us”) understands the importance of your privacy and...

Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members

See our CSR efforts As outlined in our 2023 Corporate Social Responsibility Report, we're committed to creating sustainable social change, rallying around our common purpose. Read the report...

Tap into our Expert Clinical Network Gain insights from leading key opinion leaders (KOLs) to drive better care. Breadcrumb Home Our solutions Specialty drug management Medical pharmacy Expert...